Pap Smear (Cervical Screening)
A simple procedure to detect early cell changes in the cervix. Recommended every 3 years for women aged 21–65. Detects precancerous lesions before they progress, using liquid-based cytology for higher accuracy.
Screening & Prevention · Ludhiana, Punjab
Empowering women through awareness, prevention, and early diagnosis — most gynaecological cancers are far more treatable when found early.
At Dr. Rama Sofat Hospital, Ludhiana, we believe early detection saves lives. Most gynaecological cancers — especially cervical, endometrial, ovarian, and vulvar — are far more treatable when diagnosed early. Our comprehensive screening programme combines advanced diagnostics with personalised care.
Early detection means identifying precancerous or cancerous changes before symptoms appear. It enables minimally invasive, fertility-preserving treatments, increases survival rates, and reduces the need for aggressive therapy.
Each woman receives an individualised risk assessment based on age, family history, hormonal factors, and lifestyle, followed by a customised screening plan.
A simple procedure to detect early cell changes in the cervix. Recommended every 3 years for women aged 21–65. Detects precancerous lesions before they progress, using liquid-based cytology for higher accuracy.
Identifies high-risk HPV strains responsible for most cervical cancers. Can be done alongside or instead of a Pap test. Positive results guide early intervention and counselling.
If a Pap or HPV test is abnormal, colposcopy provides a magnified view of the cervix to locate abnormal cells precisely. Targeted biopsy confirms diagnosis and guides treatment such as LEEP or cryotherapy.
Evaluates the uterus, ovaries, and endometrium. Detects endometrial hyperplasia, ovarian cysts, or early tumours — essential for irregular bleeding or post-menopausal spotting.
Performed for abnormal uterine bleeding, especially after menopause, to help diagnose endometrial cancer or precancerous conditions.
Blood tests that detect proteins associated with certain cancers — including CA-125 (ovarian/fallopian tube), CEA and CA 19-9, and AFP & β-hCG for germ-cell tumours.
For women with a strong family history of breast, ovarian, or uterine cancer. BRCA1, BRCA2, and Lynch syndrome testing identify hereditary risks and guide preventive strategies.
Used to detect precancerous changes in the vulva and vagina, especially in HPV-positive or post-menopausal women.
Every 3 years between ages 21–65. If combined with HPV testing, screening may be every 5 years as advised by your doctor.
No. It is quick, safe, and at most slightly uncomfortable.
Yes. Ovarian and endometrial cancers can run in families — genetic testing helps detect risk early.
Our specialists will perform further evaluations such as colposcopy or biopsy and guide you through personalised treatment.
Yes. It is WHO-approved and provides protection against most cancer-causing HPV types.
Early detection protects fertility, survival, and peace of mind. Our team in Ludhiana is ready to guide you.